Healthcare Integrated Technologies, Inc.
HITC · OTC
7/31/2025 | 7/31/2024 | 7/31/2023 | 7/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.03 | 0.09 | 0.10 | 0.42 |
| FCF Yield | -6.81% | -6.27% | -3.37% | -7.28% |
| EV / EBITDA | 0.00 | -11.12 | -4.83 | -3.68 |
| Quality | ||||
| ROIC | 0.00% | -287.58% | 1,397.65% | 69.09% |
| Gross Margin | 0.00% | 25.48% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.58 | 0.38 | 0.08 | 0.16 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | -899.63% | -100.15% | 45.37% | 62.49% |
| Safety | ||||
| Net Debt / EBITDA | 0.00 | -1.08 | -0.63 | -0.69 |
| Interest Coverage | 0.00 | -17.86 | -2.30 | -2.54 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | -108.98 | -11,371.59 | -12,611.13 |